Abstract

Acrodermatitis enteropathica was first recognized by Danbolt and Closs<sup>4</sup>in 1942, although cases had been previously described in the literature under a variety of titles. Further examples of the condition have been reported by Danbolt,<sup>2,3</sup>Bloom and Sobel,<sup>1</sup>Hodgson-Jones,<sup>7</sup>and Hare and Schlesinger.<sup>6</sup>The disease is now accepted as a clinical entity comprising a cutaneous eruption, gastrointestinal symptoms, and disturbances of growth and development (Sulzberger and Baer).<sup>10</sup>It has been well summarized by Dillaha et al.,<sup>5</sup>who also reported the beneficial effects of diiodohydroxyquin (Diodoquin) by mouth as suggested by Schlomovitz.<sup>9</sup>Vedder<sup>11</sup>noted the occurrence of the condition in a number of siblings. All authors agree on the presence of recurrent attacks of diarrhea or mucoid stools and an erythematous papulovesicular or pustular rash usually surrounding the orifices and on the hands and feet. Paronychia may also be a feature. Thinning

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.